Elanco Animal Health Incorporat (ELAN) Stock Analysis
Healthcare · Drug Manufacturers - Specialty & Generic
Sell if holding. Momentum 2.5/10 is below the 5.0 floor at $22.05 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Earnings in 6 days (event risk).
Elanco Animal Health is a global animal health company selling ~200 branded products for pet health (parasiticides, dermatology, vaccines) and farm animals (antibiotics, productivity enhancers) in 90+ countries, with the U.S. accounting for 47% of 2025 total revenue. Revenue is... Read more
Sell if holding. Momentum 2.5/10 is below the 5.0 floor at $22.05 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Earnings in 6 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.2/10, moderate confidence.
Passes 4/6 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and earnings proximity 6d<=7d. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProducttop five products and/or product families38%10-K Item 1A: 'Our top five products and/or product families, Advantage Family, Seresto, Credelio Family, Rumensin and Maxiban / Monteban represented approximately 38% of our total revenue in 2025'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers·1 ceiling hit
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 2.5/10 is below the 5.0 floor at $22.05 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Earnings in 6 days (event risk). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $20.97. Score 5.2/10, moderate confidence.
Take-profit target: $24.86 (+12.8% upside). Prior stop was $20.97. Stop-loss: $20.97.
Earnings in 6 days (event risk); Negative momentum.
Elanco Animal Health Incorporat trades at a P/E of N/A (forward 18.7). TrendMatrix value score: 5.4/10. Verdict: Sell.
22 analysts cover ELAN with a consensus score of 4.3/5. Average price target: $29.
What does Elanco Animal Health Incorporat do?Elanco Animal Health is a global animal health company selling ~200 branded products for pet health (parasiticides,...
Elanco Animal Health is a global animal health company selling ~200 branded products for pet health (parasiticides, dermatology, vaccines) and farm animals (antibiotics, productivity enhancers) in 90+ countries, with the U.S. accounting for 47% of 2025 total revenue. Revenue is earned through distributors, veterinarians, and direct sales to farm animal producers across multiple species.